Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122115714 | 12211571 | 4 | F | 201604 | 20160822 | 20160325 | 20160830 | PER | US-CELGENEUS-USA-2016035807 | CELGENE | 74.44 | YR | F | Y | 66.28000 | KG | 20160830 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122115714 | 12211571 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | N | U | A2131A,A2116A,A2156C | 21880 | 25 | MG | CAPSULES | QD | ||||
| 122115714 | 12211571 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | N | U | A2131A,A2116A,A2156C | 21880 | 20 | MG | CAPSULES | QD | ||||
| 122115714 | 12211571 | 3 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | N | U | A2131A,A2116A,A2156C | 21880 | 20 | MG | CAPSULES | QD | ||||
| 122115714 | 12211571 | 4 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | N | U | A2131A,A2116A,A2156C | 21880 | 10 | MG | CAPSULES | |||||
| 122115714 | 12211571 | 5 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | U | 0 | UNKNOWN | ||||||||
| 122115714 | 12211571 | 6 | C | Warfarin | WARFARIN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 122115714 | 12211571 | 7 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 122115714 | 12211571 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 122115714 | 12211571 | 9 | C | IMODIUM | LOPERAMIDE HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 122115714 | 12211571 | 10 | C | Intestinex | 2 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122115714 | 12211571 | 1 | Plasma cell myeloma recurrent |
| 122115714 | 12211571 | 5 | Product used for unknown indication |
| 122115714 | 12211571 | 6 | Product used for unknown indication |
| 122115714 | 12211571 | 7 | Product used for unknown indication |
| 122115714 | 12211571 | 8 | Product used for unknown indication |
| 122115714 | 12211571 | 9 | Product used for unknown indication |
| 122115714 | 12211571 | 10 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122115714 | 12211571 | Abdominal discomfort | |
| 122115714 | 12211571 | Abdominal pain upper | |
| 122115714 | 12211571 | Asthenia | |
| 122115714 | 12211571 | Constipation | |
| 122115714 | 12211571 | Decreased appetite | |
| 122115714 | 12211571 | Diarrhoea | |
| 122115714 | 12211571 | Dyspepsia | |
| 122115714 | 12211571 | Dysphonia | |
| 122115714 | 12211571 | Fatigue | |
| 122115714 | 12211571 | Gastrooesophageal reflux disease | |
| 122115714 | 12211571 | Hyperhidrosis | |
| 122115714 | 12211571 | Insomnia | |
| 122115714 | 12211571 | Memory impairment | |
| 122115714 | 12211571 | Nasopharyngitis | |
| 122115714 | 12211571 | Somnolence | |
| 122115714 | 12211571 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122115714 | 12211571 | 1 | 201309 | 0 | ||
| 122115714 | 12211571 | 2 | 201310 | 2015 | 0 | |
| 122115714 | 12211571 | 3 | 20160216 | 0 | ||
| 122115714 | 12211571 | 4 | 20160427 | 0 |